the safety of quinapril hydrochloride , a new nonsulfhydryl angiotensin-converting enzyme ( ace ) inhibitor with an intermediate duration of action , has been evaluated in 3,031 patients with hypertension and congestive heart failure ( chf ) and has been compared with other ace inhibitors .
C0770920
quinapril hydrochloride
C0018802
congestive